An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Chang-Hee Lee, M.D
Green Cross Corporation
Study Director - Doyeun Oh, M.D., Ph.D.
CHA Bundang Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chungnam National University Hospital
Daejeon, South Korea
- Daegu Catholic University Medical Center
Deagu, South Korea
- Chonnam National University Hwasun Hospital
Hwasun, South Korea
- Gachon University Gil Medical Center
Incheon, South Korea
- Chonbuk National University Hospital
Jeonju, South Korea
- Pusan National University Hospital
Pusan, South Korea
- Seoul National University Bundang Hospital
Seongnam, South Korea
- Asan Medical Center
Seoul, South Korea
- Cha Budang Medical Center
Seoul, South Korea
- Ewha Womans University Medical Center
Seoul, South Korea
- Samsung Medical Center
Seoul, South Korea
- Severance Hospital
Seoul, South Korea
- Soon Chung Hyang University Hospital
Seoul, South Korea
- Vhs Medical Center
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 30 Apr 2016
- Completion
- 30 Apr 2016
- Last update posted
- 25 May 2016
- Registered enrollment
- 81
- Registry id
- NCT02063789
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.